skysight-inc/HackerNews huggingface dataset:
In parallel:

1) Produce publicly visible artifacts which demonstrate that you're able to apply technology to impact business outcomes. You do not need many of these; ~3 is fine. You do not need to block on the other steps. You do need to plausibly connect the technology to a business outcome; blockchain and beginner-level cryptography probably do not get you there.

2) Begin getting into conversations with people who either a) have purchasing authority or b) talk to people with purchasing authority, at your target clients or firms very similar to them. This can be as simple as bonding over technical things with technical people. You want to become Internet buddies with e.g. senior engineers / team leads / etc at software companies.

3) Walk the network of your new friends to engagements, either at their firms or peer firms. Do not make another WordPress site for the average business; make something for a software company.

4) For every engagement you land, attempt to get referrals to more clients, attempt to land follow-on work with the same client, and attempt to land ongoing maintenance/retainer/etc agreements with the client.

And then: https://news.ycombinator.com/item?id=4247615
As someone who has just left the advertising industry, and was doing data stuff, the real issue is that a lot of companies have a lot of data but almost none of it has any actual useful information content in it. It’s a bit of a hard concept to explain to explain to people because they go “but there’s a hundred something columns, and hundreds of millions of rows!”, you can have all the data you want, but if it’s all non-indicative trash you’re not going to be able to usefully predict anything, but hey, you’ve hired a data scientist now and added the cost of a big spark cluster to your AWS bill now, so you may as well continue telling the market you’ve got some real hot stuff.
It doesn’t have anything to do with occupants. Condos can be rented out too. It’s a legal term having to do with division of titles, common area ownership, etc
This would be interesting if combined with something like BAT or AdSense or Coinhive to earn revenue from viewing then use that revenue to pay for seeding via something like Sia/ Filecoin.
> Never mind, just keeping track of where an individual machine is in a data center (needle in a haystack).

I have a friend who contracted to develop a custom DHCP server to allocate addresses based on Ethernet ports. This is superior to static IP configuration because you invariably make configuration mistakes.

Cisco provides this feature, but Cisco is expensive, hence a lucrative side job for my friend. There seems to be lots and lots of opportunities like this to provide custom softwares for mining farm.
An interesting question.

One potential issue perhaps would be that it would presumably violate the memorylessness principle, which really changes the mining dynamics.

Is there a difference between what you're proposing and the more memory-intensive hash algos like Scrypt, etc?
My favorite examples:

http://www4.cs.fau.de/Projects/JX/

https://www.jopdesign.com

https://www.cs.cornell.edu/Info/People/chichao/sip99.pdf

https://www.azul.com/products/vega-processor/

Although I don't keep them bookmarked, I looked into my collection of real-time or embedded GC's to find these that you might feel inspired by or see as potentially useful. :)

https://www.diva-portal.org/smash/get/diva2:20899/FULLTEXT01...

http://www.vmars.tuwien.ac.at/documents/extern/3017/diss_puf...

https://researcher.watson.ibm.com/researcher/files/us-bacon/...

http://realtimegarbagecollector.com
I think the language has huge bang for buck. It's fast, it's simple, it has excellent tooling and libraries. I can't see a similar value proposition anywhere else.
Did Rome suffer from more fires than similar cities in that era? Something tells me it's the other way around...

On average, group behavior can best be studied when assuming average humans have selfish, rational motivations. It's possible to create incentives in the public sector but you can imagine it would be much like academia -- a focus on pushing out high volumes of papers, getting grants, and theoretical/laboratory breakthroughs without any consideration of bringing them to market.

Most of the breakthroughs in medicine used by countries around the world were invented in the US and originally held by US companies -- the US has effectively subsidized and enabled foreign socialized healthcare systems by being a global exporter of medical technology. So the US adopting a state run medical system would likely have an interesting effect on the global medicine market, in a way much different than any other country (i.e. a massive reduction in global progress).

Most people advocating that seem to think the US system is a failed example of a 'free marketplace,' which is an embarrassingly incorrect belief but a product of significant misinformation littering both sides of the argument these days. The US healthcare system is in most ways further from a free market than that of any other country I know of. First of all, we have universal healthcare but only for the elderly (medicare) and the poor (medicaid), which creates an artificial demand imbalance that pumps the prices up for non-participants in those programs, which is even worse than a singular universal system. Then look at the ridiculously overpowered IP law in the US (especially in pharmaceuticals), the oppressive occupational licensing (harder to become a doctor here than anywhere else so naturally we have an artificial shortage of people qualified to do mostly very basic things), FDA-imposed pharmaceutical monopolies, inability to opt-in to experimental treatment (which also means malpractice insurance is always a significant expense), amongst others. This is not a free market, and even if we adopted universal healthcare tomorrow, it does not fix all the other problems listed.
>Are you saying there are network engineers/management at ISPs who don't believe IPv6 is an imperative?

Unfortunately, this is true for at least one major ISP in the USA. IPv6 support is seen as a low priority internally, as they work to merely keep their devices online.

One huge secret about Juniper devices is that the hardware is remarkably unreliable. At one company, a partial Juniper SSG failure prevented a failover to good hardware. At another, we so many Juniper SRX RMAs that we had a full time network engineer handling the RMA paperwork. (Admittedly, they said we were their biggest client, and had a bigger implementation than Juniper's own network lab.) They have a bad habit of failing on reboot - one was operating fine, we reboot it and it reports errors. This happened repeatedly in several data centers - at one point we had 1/6 of our data centers non-redundant while we waited for RMA shipping.
Disney as a company was also completely built upon old stories in the public domain, but as soon as they became successful they started tightening the screws on intellectual property laws to make sure that others couldn't do the same.
Special Diet Kept the Knights Templar Fighting Fit
I agree that halting the car could be very dangerous. But an alarm might be worthwhile.

And if the car has not moved in say, 15 minutes, then shut it off (but allow it to be restarted - no lockout).
> Facebook data exports don't contain this data

Facebook does have demographics and targeting data. Go to Setting -> Ads -> Your Information -> Your Categories. I haven't found a way to export it.

On the categorization side, Facebook does a half decent job considering I don't upload anything on FB or any other sister sites.

Twitter on the other hand might be running algorithm which tries to extrapolate too much from the available data.
Why do you think PoS is workable in the long run? I'm hesitant about the implications of solely tying voting power to how much currency you hold.

Hash rate isn't much better, since it's the definition of a capital-intensive business, but there's still some possibility of getting better performance through clever innovations
I completely disagree. I learned Java after C++ and I found it to be a breeze to learn - and I was self taught. Python is a good language too, granted.
Again, that might be true, but it rings multiple alarm bells when I actually think about it.

First, it assumes that the profit margins of a company remain constant. Again, companies want to make money. Period. So say that you're a pharmaceutical company and you're currently getting back 250% of your costs for a drug over the exclusivity period.

If we double that exclusivity period, you are not going to decrease the price you charge or the amount you invest into marketing so that your return on investment remains 250%. At least, not if you're a good business owner. You're going to double down on the exact same strategy and make 500% return. If I later halve your exclusivity period, you won't stay at 500%. You'll go back to 250%.

The fact that a company has less time to do marketing does actually suggest to me that marketing becomes a less bulletproof, desirable strategy for making money - which is exactly what the author wants. It might still be a bad idea; maybe pricing becomes the most efficient way to generate profit, or maybe the drug industry has such tight margins that there is no efficient way to generate profit and everyone closes up shop.

But it seems at least somewhat reasonable to say that if you expect the cost of marketing to remain constant, and the return per dollar to go down severely, you invest less into the now inefficient strategy.

The other reason that I have difficulty accepting this claim at face value is because I can think of markets where it just isn't true: for example, mobile apps. Nobody smart is investing huge amounts of money into marketing a mobile app. What they're doing is churning out five apps a week on the hope that one of them goes viral.

The lack of exclusivity in that market means that constant development is basically a requirement to keep your head above water.

Now, do we want our drug industry to look like the mobile app market? The mobile market is so opposed to long-term investment that the majority of games and apps developed there are rushed-to-market crap. So we probably don't want our drug research to operate the same way.

But I don't think it's immediately unreasonable that there might be a middle ground we could hit between 20+ years of exclusivity and 4 days of exclusivity.
Nearly all my work at this time is in C++, Rust, Python, and JavaScript. Thanks to pipenv, Python environments finally feel on par with Rust/cargo and NodeJS/Yarn.

C++, though, still a mess to get an isolated build environment there. Meson and Bazel are close, so close...
What I found interesting about his MO when I read Takedown was the idea of social engineering and stringing together scripts. In particular Mitnick was interesting because it was a counter-narrative to the world Stoll portrays in The Cuckoo's Egg, a world where only technical knowledge seemed to matter in relation to technical issues. I suppose I found Mitnick M.O. interesting because it was so much simpler...like the scene in Raiders of the Lost Arch where Jones faces the swordsman [sans violence]. Not that he was my hero or anything. But I never found myself relating Shimomura in the way I did with Stoll. My recollection is that his book felt like a knockoff written with the expectation that I should feel outrage. I didn't.

Stoll was the most interesting character in his book. Mitnick was far and away the most interesting character in Shimomura's book. Stoll was interesting because he was curious. Shimomura was dull because he was just offended. The book did well because Mitnick was interesting, because cloning cell phones was interesting, because breaking into computer systems is interesting...even to people who aren't going to do it.
If you can’t distinguish between “you should take this pill” and “you should consult a medical professional,” we have little to discuss.

If you think someone telling you they considered killing themselves to be a high point isn’t at all concerning, we have nothing to discuss at all.
Using the `golang:1.10-alpine` image to run your binary would defeat the purpose of a multi-stage build, since it includes everything needed to compile Go and weighs in around 376MB. The `alpine:3.7` image is about 4MB.

edit

I misunderstood the parent, they meant to use `golang:1.10-alpine` as the build image, not the run image, as in:

FROM golang:1.10-alpine
COPY . /go/src/bitbucket.code.company-name.com.au/scm/code
WORKDIR /go/src/bitbucket.code.company-name.com.au/scm/code/
RUN go build main.go

FROM alpine:3.7
RUN apk add --no-cache ca-certificates
COPY --from=0 /go/src/bitbucket.code.company-name.com.au/scm/code/main .
CMD ["./main"]

Which works! Thank you!
It makes a substantial difference when we're talking about open software the distributor builds from source. The major distributors set a relatively high standard for the build process.

The same cannot be said for developers in my experience, who often don't even see a problem with the build process accessing the network - and frequently will publish releases built from the same host environment they use for their general daily computing.

From the perspective of a distributor, the packages should be perfectly buildable (and for official releases, preferably so) with a toolchain of known provenance in a clean environment without network connectivity.

The priorities are quite different for the developer of software and the distributor of systems incorporating that software. It's similar to the tension between system administrators and developers.
Tolkein may also have talked with trees, so a bit of a quirky fellow, for which we can all be grateful.
No, use golang:1.10-alpine for the build, keep the second stage the same.
That's not true. If the US had a centralised health system like other developed countries they would have the same bargaining power. In NZ we have Pharmac who bulk purchases drugs for the country, they can get good deals because they operate in a free market and can play the pharma companies off each other.

Don't blame other countries for your own governments inability to bargain.

Pharma companies still have patents and exclusivity deals. They will price the drug at a point where it's profitable, and countries will buy those drugs if they work.
Personal websites served two purposes:

1) You could write about whatever you were interested in.

2) You could share things you had found on the web with others.

These days, (1) has been superseded by YouTube and Facebook groups, and (2) has been superseded by Wikipedia/Google/YouTube.
Amazon has the rights Netflix would want, and Netflix isn't going to subsidize a property that is a competitive advantage for Amazon in the key market (and, conversely, Amazon would rather let the property die than let Netflix have the streaming rights.) So, if SyFy isn't going to carry the load, it's probably either Amazon taking over or it dies.
From another comment here, X16R?

https://ravencoin.org/wp-content/uploads/2018/03/X16R-Whitep...
I code C# for a living and I still prefer Java. A lot of the things added to C# are mis-features IMO. When stuff gets added to Java it's usually been thought out better than the way MS used to cram new features into C#. I quick look at C++ ought to show that every feature under the sun isn't always the best approach.
I take issue with your "professionals who only know Java" line. I knew C, C++, Lisp, Pascal and Assembler before coding Java. I've learned C#, Javascript, Python and Rust since. I still consider Java one of my favourite languages. It's a pretty poor ad-hominem argument.
Cat right mew
Are you sure that the "R&D" numbers you saw represent all the costs of developing a new drug and bringing it to market?
I thought the whole .Net Framework/.Net Core/.Net Standard distinction was crazy. But the more I read about the Oracle JDK vs OpenJDK and the difference in the support schedule and licensing, I find that Microsoft's strategy is much more understandable.

And as far as the LTS version of Java, 3 years seems a little long to wait for any updates but 6 months seems short to to drop support.

If I ever get back into Java, it will be solely for Android development. Does any of this affect Android development?

I haven't used Java in years, is the Java ecosystem under Oracle as bad as it appears from the outside?
If you don’t go to folk’s funerals how can you expect them to come to yours?
sure. It used to be that major releases were tied with major features. InvokeDynamic on 7, Lambdas on 8, Jigsaw on 9. So since these were the features that were expected, the release only shipped when they were fully baked. Now is on a train-release model. You get whatever is ready to ship (big features can't delay a release anymore).
It came up here on HN just a week or two ago.
The reason for the advertising in NZ is that Pharmac will often fully fund generics, if you want to buy the brand name drug you have to pay extra on top. For instance, I just got a new prescription for inhalers, the pharmacy told me if I wanted ventolin it would be $5 but the generic was fully subsidised.
People seem to forget that if something isn't great, that doesn't mean it's bad.

VB, Carlton, Budweiser, or any other mass market lager isn't bad beer. It's not good beer, there's nothing remarkable about the stuff, but it's not like it's vinegar or has massive technical flaws. The quality control and consistency of mass market lagers is something that many craft breweries and brewpubs could only dream of.

There's plenty of craft beer that I've drunk that's distinctly different from batch to batch, their consistency is all over the show. But I know that if I get a stubby of VB, it's going to taste exactly like VB.
I don’t understand how comparing it to the GDP of small foreign countries adds context. The important context is what I stated: it’s about $300 per person. That means that it’s a very small portion of our ~$10,000/year per capita health care expenditures. Anyone who knows how much their health insurance costs per year can immediately see how much of that funds their share of pharma R&D. The answer will almost always be “not very much.”
Show HN: aws_public_ips, a tool to fetch all public IPs tied to an AWS account
In practice, none. I just think contract law is interesting.
The reality is that governments have demonstrated limited interest in effective biomedical R&D. Europe does not invest proportional to their population or economy, their governments are happy to outsource it to the US (and Asian) private sector. And there is the longstanding issue that what governments do fund is biased by political fashion and not the areas of research that will maximize benefit. There has been a huge growth in private foundations that fund biomedical research that governments should fund but do not.

Also, pharma researchers will accept massive pay cuts "for the science and the cause" as soon as Silicon Valley software engineers take massive pay cuts "to make the world a better place". I have many friends in biotech and they are as interested in maximizing their paycheck as software engineers, it would be naive to expect anything different.
Super good customer support. Highly recommended. Awesome product so far, blurring the lines between traditional web design and development.
These two are like 190-195kg. A lot certainly but not five times.

Even Andre The Giant is billed "only" at 236kg.
I always use pv when I want to monitor a long running operation, mainly because it shows the rate of progress as well as the ETA for the operation (of course, this is an estimate, but it's still useful).

'man pv' is a short read and is something anyone who want to monitor such things should read.
While arguing with people with people (who are attempting to help you) coupled with displays of intellectual stotting when you feel threatened, may seem like a good way to get a job offer, ask yourself: “How is that working out for me so far?”
Surely though the best marketing is the effectiveness of the product, if it's a good product then doctors will prescribe it.

I don't know if it's true or not, but looking at US movies/tv shows it seems like everyones taking medication which I doubt they actually need. Here I don't know very many people who actively take regular medication, I know that people who move here complain at how doctors are stingy with prescriptions, yet life expectancy is longer than the US.
> If we take the somewhat liberal assumption that pharma's marketing budget is ecomically optimal at present - eg marginal costs equal marginal revenue

Do we take that assumption?

Sure, if we take the assumption that we're operating at perfect efficiency already, then I suppose there's no need to mess up an already good system. And maybe we are; I've even seen a few articles suggesting that we're suboptimal, that pharma is bleeding money at the moment. In which case, maybe the takeaway is the opposite, that we should extend exclusivity to 25 years or something.

But that's a very different claim to make. I suspect that the author of the linked article would claim that pharma is not at all optimal, and I suspect that any entrenched industry in a large market being optimal is the exception rather than the rule.

I think it's generally a mistake to assume that things cost a lot because they have to. Often in a free market it is because of large (solvable) inefficiencies or bad business practices, which is exactly what enables newer industries and businesses to out-compete and displace older ones.
Do you remember what the anime adaptation was called?
#!/bin/sh

for pid in $@; do
cd /proc/"$pid"/fd || continue

for fd in *; do
file=$(readlink "$fd");
if [ ! -z "$file" ]; then
size=$( (du -b "$file" 2>/dev/null || echo 0) | awk '{print $1}')
if [ "$size" = "0" ]; then
continue
fi

pos=$(< ../fdinfo/"$fd" grep -F 'pos:' | grep -oP '\d+')

percent=$(echo "100*${pos}/${size}" | bc -l | xargs printf "%2.2f")
echo "${file}: ${percent}% (${pos}/${size})"
fi
done
done
Somehow forcing others to pay more rather than forcing the companies to charge less for everyone is the free market at work...
I've done a lot of googling on them. Even found the new Gabe Evans... https://github.com/ivy (good for her).

Had they invested their $500k in BTC in 2015 instead of HashRabbit... 100m btc @ ~$200 = $1b.

It seems like they aren't really in business. Is there something you know that I don't?
Great? Most people are HN readers who can do this sort of thing. Most people have "tv that can just show tv" and "new technology that can also embed netflix or whatever" as options.
Certainly better for girls than almost anything anime.
Usually? No.

Unless you're compensated multiple times what a no-warranty version would cost, and do it for an industry where bug-free matters. And even then that's a question for the company lawyers as well. In short: if you ask on HN, it's almost certain you shouldn't try.

What you may be interested in is some form of a license / retainer, where you're available to the company as a contractor for X amount of time to fix potential issues raised. But don't ever mention bug-free and rent out your time, not results.
Twitter is the same, except even more-so. People tweet 10+ times a day, update FB status infrequently.

All the things FB has done to extract things like resturant data etc are product development they undertook. Twitter spent 10 years moving form 140 characters to 280 instead.
Private industry generously rewards innovation

The drug industry is generally happier to develop new drugs against targets that are well established and for conditions that physicians are trained to prescribe for. That's why we are now at fifth-generation statins, and also why "first-in-class" compounds are so rare.

For something really new you need to find the target, devise an assay and make a case for use. It's a billion-dollar gamble. Statins on the other hand, they are well established.
Most residential customers don't have static IP addresses -- how does that work when a customer's IPv4 address changes?
Time for some taxes on foreign property ownership or uninhabited buildings then.